Shares of AstraZeneca AZN, -0.75% AZN + 3.16% They fell 3.4% in trade on Monday after a medical journal published a study that found the company’s COVID-19 vaccine candidate produced antibody and T-cell responses in participants in a phase 1/2 clinical trial. . AstraZeneca is developing the experimental vaccine with …
Read More »AstraZeneca stocks drop 3% as results of early-stage study on coronavirus vaccine released
